KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Enterprise Value (2016 - 2025)

Cme (CME) has disclosed Enterprise Value for 17 consecutive years, with -$125.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 95.84% to -$125.0 million in Q4 2025 year-over-year; TTM through Sep 2025 was -$2.6 billion, a 2063.3% decrease, with the full-year FY2025 number at -$125.0 million, up 95.84% from a year prior.
  • Enterprise Value was -$125.0 million for Q4 2025 at Cme, up from -$2.6 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$81.7 million in Q1 2021 to a low of -$3.0 billion in Q4 2023.
  • A 5-year average of -$1.2 billion and a median of -$823.0 million in 2024 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: plummeted 2538.07% in 2022, then skyrocketed 95.84% in 2025.
  • Cme's Enterprise Value stood at -$119.8 million in 2021, then tumbled by 2250.67% to -$2.8 billion in 2022, then decreased by 7.37% to -$3.0 billion in 2023, then rose by 0.6% to -$3.0 billion in 2024, then surged by 95.84% to -$125.0 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Enterprise Value are -$125.0 million (Q4 2025), -$2.6 billion (Q3 2025), and -$117.6 million (Q2 2025).